Créée en 2014 (États-Unis), BASAGLARA possède 588 marques sœurs et 17479 marques concurrentes. BASAGLARA appartient à ELI LILLY AND COMPANY, cotée à la bourse de New York. BASAGLARA appartient au secteur d’activité Fabricants de médicaments.
Acheter l'action ELI LILLY AND COMPANY avec
(0% de commission et fractions d'actions)
Votre capital est assujetti à un risque. D'autres frais s'appliquent. Pour plus d'informations, rendez-vous sur etoro.com/trading/fees.
Autres marques
ELI LILLY AND COMPANY
-
A
- Avid Radiopharmaceuticals
- Alnara Pharmaceuticals
- Applied Molecular Evolution
- AurKa Pharma
- AUMBIQUE
- AUMBIQ
- ABAYSAGLAR
- AXIRON TWIST & DOSE
- ABASAGLAR
- ACCOMPLISH
- APLEVOW
- APLEVOS
- APLEVO CERTUIT
- APLEVO CRUISIT
- APLEVO FLASHTEC
- APLEVO INTELIVA
- APLEVO JILITY
- APLEVO SWIFTEC
- APLEVO SWIFTUIT
- APLEVO TRUITION
- APLEVO VERSTIA
- AFIGILE
- ABAZRIA
- AMYVID
- APPELLUS
- ANELYNE
- ALIBRET
- APLEEVO
- ANNCYZ
- ANNCYZE
- APLEVEO
- ARRYZING
- ARYZING
- ABASRIA
- AXXERON
- ATONZIA
- AMODIF
- AXIRON
- ADCIRCA
- AMYLYTE
- AMYSCAN
- AMYPET
- AMYVUE
- AXERON
- ARMAMENT
- ANDEPTRA
- ADVACADE
- AKODAR
- APLEVANT
- APLEVOL
- APLEAVO
- APLEVO
- ACIRQA
- ADCIRQA
- ARICLAIM
- ARXXANT
- ANSWERS THAT MATTER
- ANDEPRA
- ARXANT
- ARVANT
- ATENTEN
- APTHELA
- ALIMTA
- ARMAVE
- AMZET
- AXID
-
B
-
C
- CoLucid Pharmaceuticals
- CESLADA
- CYRAMZA
- CERTAMARK
- CERTUIT
- CYRAMZE
- CYRAMZO
- CYRRAMZ
- CYRAMGIO
- CYRAMZ
- CIAVOR
- CEZYCE
- CORPOMIN
- CORGLUTRIS
- CORGLUTAN
- CORGLUTAL
- CYRRAMZA
- CYRAMZZA
- CYRAMZZ
- CYRAMSA
- CYLIFRA
- CERYOND
- COPELLOR
- COHEALEN
- CONTINULON
- CIRAMZ
- CIRAMZA
- CHERISTIN
- CONVERGIS
- CHERSTIVA
- CONQUEST
- C20
- C10
- CERENTRA
- CREAZOX
- CYMBALTA
- COYOTE
- CY-OTE
- CYVADE
- CHEF1
- CYMBALTA BECAUSE DEPRESSION HURTS
- COMFORTIS
- CIALIS
-
D
-
E
- ElanCopro
- ELANCO MYVETPROGRAM
- ELCEVEVE
- ENEVYBE
- EVABAVE
- EVABECT
- ELIVRAL
- EFERLEZ
- ELUNATEY
- ESENGLAR
- EMUGLAR
- ELANCO KETO-TRACK
- ELUNATY
- ELYUNATE
- ENDEVRON
- EXPERIOR
- EXPIDANN
- EASYHOLD
- EMMECENT
- EBLINIAL
- EBZYVE
- EMBLACE
- ELIVRIAL
- EMVENIA
- ESUVEL
- EZAMBRISS
- EZAMBBRIS
- EZEMBRIS
- ENGLUCENT
- EGLUCENT
- ELUNATE
- EPARVIV
- EPARVIVE
- EPAREM
- ENTHRYV
- EXPIDAN
- EZAMBRIS
- ENVILLOW
- ETUNITY
- EMBOLZEN
- EZOLVEN
- ESSENCIL
- ENZAVA
- ENCLUSION
- ENKINDA
- EFIENT
- ELMETRA
- ELAMETRA
- ELEMETRA
- EFFEANT
- EFIANTE
- EFFEANTE
- ERBITUX
- EFFIENT
- ENTUZITY
- ERBITUX CETUXIMAB
- ENDOCLONE
- ERBLOC
- EXTINOSAD
- ELANTIL
- ELANTIK
- ELECTOR
- ELANCID
- ELATRIM
- ELANCO ANIMAL HEALTH HTS Health Tracking System
- ELANCO
-
F
-
G
-
H
- Hypnion
- Heart Rhythm Technologies
- HALPRYZA
- HYBREED
- HEALTHY START
- HARMONTA
- HARMONDRA
- HARMONTRI
- HARMONTRU
- HARMONTRY
- HARMONTRO
- HAVEN
- HARMONNTRA
- HARMONTTRA
- HARMONTRA
- HUMAPEN SAVVIO
- HABEREX
- HTSi
- HUMABELA
- HUMAPEN
- HUMAHALE
- HUMALOG BAZAL
- HUMALOG MYPEN
- HUMALOG KWIKPEN
- HUMALOG CONFIPEN
- HEMICELL
- HUMABASE
- HUMALOG SAVVIO
- HUMALOG MIRIO
- HUMALOG INZIO
- HUMAPEN ERGO
- HUMAPEN MEMOIR
- HUMAPEN LUXURA
- HUMATROPEN
- HUMALOG MIX25
- HUMALOG MIX50
- HUMALOG MIX75
- HUMATROPE
-
I
-
J
-
K
-
L
-
M
-
N
-
O
-
P
- PLYNAMIC
- PORTRAZZA
- PIGTRACK
- PERPETIUM
- PLATFORM
- PACE A Lilly Oncology Initiative
- PORTRAZZ
- PORTTRAZA
- PORRTRAZA
- PONTTEVIA
- PONSTEVIA
- PONTREVIA
- PAVENI
- PD2 PHENOTYPIC DRUG DISCOVERY
- PACEVIOR
- PACEVIOS
- PLAQUEVID
- PONTEVIA
- PORTRAZA
- PLINIAD
- PALOMYS
- PANORAMIS
- PALOMYPEN
- PRENU
- PATHGATE
- PERTINENZ
- Peaks & Valleys
- PALOMIS
- PAFASE
- PASPORT
- POZIQ
- POZIQUE
- PEMTAZAR
- PROMTAR
- PROZAC
-
Q
-
R
-
S
- STARTGLAR
- SHINE
- SAVVIOCONNECT
- SCRATCH TRACKER
- STEADYGRIP
- STANCE
- SUROSOLVE
- STAURENZA
- SEQUNE
- SEFFONY
- SPURVIXA
- SILLPURA
- SOLLPURA
- SKYCIS
- SELF EXPRESSIONS OF PAIN
- SEFONY
- STYLAPEN
- SURMAX
- STAURENZAKT
- STAURENZAK
- SAVVIOPEN
- STANDGUARD
- SYLVATA
- SOHO SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES
- STRATTERA
- STELLAMUNE
- SOLPURA
- SGX Pharmaceuticals
-
T
- THE ELANCO PULSE INSTITUTE
- TAUVID
- TANGLEVID
- TWIST & DOSE
- TALTZ
- TRUEHOLD
- TRUEGRIP
- THE SOCIAL VETWORK
- TRENUVIS
- TECULEN
- TARGET D2 TARGET DRUG DISCOVERY
- TRUNEXUS
- TANSTRIVE
- TIRVEO
- TAZLUM
- TOLIENT
- TEAMMATE
- TRAILHEAD
- TRANSGEVITY
- TRIFEXIS
- TRITECTIS
- TURZINE
- Targeted Oncology
- THE LILLY MDR-TB PARTNERSHIP
- TREONFA
- TOPMAX
- TYFOLAR
- TACLERON
- TYLAN
- Togirén
-
U
-
V
-
W
-
X
-
Y
-
Z
- ZELUNATE
- ZORBIUM
- ZECIFFIN
- ZINLISTIQ
- ZANLISTIQ
- ZANLISTIC
- ZYSE
- ZIPSTA
- ZEAVE
- ZENEFOST
- ZENLISTIC
- ZERMAVA
- ZIMPROVA
- ZOXI
- ZYRELPREV
- ZYPRELPREV
- ZYREZVO
- ZYPREZVO
- ZEARL
- ZYPHE
- ZYPREXA
- ZALUTRIA
- ZAFIANT
- ZEFYANT
- ZEFIENT
- ZYADHERA
- ZADHERA
- ZYPADHERA
- ZYPREXARELPREV
- ZYPREXADHERA
- ZYPREXAREZVO
- ZYPREXA ADHERA
- ZELLETRA
- ZALUTIA
- ZYMERYS
- ZEFFIANT
- ZEFIANT
-
4